ArticleFrontiers in cellular and infection microbiology2025
Development and validation of a multidimensional predictive model for 28-day mortality in ICU patients with bloodstream infections: a cohort study.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Construction and validation of a predictive model for mortality risk in patients with Staphylococcus aureus bloodstream infection.BMC infectious diseases · 2026Article
- Comparison and validation of multiple machine learning algorithms for predicting MDRO infection in catheter-related bloodstream patients: a multicenter cohort study.Microbiology spectrum · 2026Article
- Development and validation of a prognostic nomogram model for 28-day mortality based on IP-10 and clinical parameters in septic patients in the emergency department.Frontiers in cellular and infection microbiology · 2026Article
- Association of the atherogenic index of plasma with in-hospital mortality in patients with sepsis-induced coagulopathy.Lipids in health and disease · 2025Article
- Early diagnosis and prognostic prediction of secondary bloodstream infections caused byFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bloodstream infections (BSI) are a leading cause of sepsis and death in intensive care unit (ICU). Traditional severity scores, including the Sequential Organ Failure Assessment (SOFA), Acute Physiology Score III (APSIII), and Simplified Acute Physiology Score II (SAPS II), exhibit limitations in effectively predicting mortality among BSI patients, primarily due to their reliance on a narrow range of clinical variables. This study aimed to develop and validate a comprehensive nomogram model for 28-day all-cause mortality prediction in BSI patients. Methods: A retrospective cohort study was conducted using data from 3,615 patients with positive blood cultures from the MIMIC-IV database, divided into training (n=2,532) and validation (n=1,083) cohorts. Through a two-step variable selection process combining LASSO regression and Boruta algorithm, we identified 12 predictive variables from 58 initial clinical parameters. The model's performance was evaluated using AUROC, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA). Results: The nomogram demonstrated superior discrimination (AUROC: 0.760 Conclusions: This study developed and validated a predictive model for 28-day mortality in BSI patients that demonstrated superior performance compared to traditional severity scores. By integrating clinical, laboratory, and treatment-related variables, the model provides a more comprehensive approach to risk stratification. These findings highlight its potential for improving early identification of high-risk patients and guiding clinical decision-making, though further prospective validation is needed to confirm its generalizability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.